Cervical cancer is one of the most common cancers worldwide, despite the availability of
preventive and diagnostic methods. Progression to cancerous changes takes a long time.
Infection with human papillomavirus (HPV) plays a crucial role, but not the only one.
Recent studies increasingly show that multiple viral, immunological, hormonal, and
microbiological factors influence the course and progression of the infection. This review
aims to summarize current knowledge on the mechanisms of HPV-dependent
carcinogenesis, with particular emphasis on the role of vaginal microflora,
environmental factors, and modern methods of prevention and diagnosis. This review
draws on 17 scientific papers published between 2011 and 2025, found through searches
in PubMed, Scopus, and Google Scholar. Disruption of the vaginal microbiome may
contribute to the persistence of HPV infection. A decrease in Lactobacillus bacteria and
an increase in anaerobic bacteria lead to inflammation and oxidative stress, which may
facilitate the integration of viral DNA into the host genome. There is increasing emphasis
on new diagnostic methods. Testing for epigenetic methylation markers (e.g., CADM1,
MAL) may improve the specificity of molecular tests. HPV vaccination is known to be a
preventive measure against CIN2+ lesions and cervical cancer. Restoring normal vaginal
microflora through the use of probiotics may be an important element in the prevention
and treatment of HPV infections in the future. The most effective way to decrease
incidence may be to combine comprehensive vaccination programs with modern,
integrated screening strategies.
Keywords: cervical cancer, epigenetic biomarkers, human papillomavirus (HPV),
microbiota, prevention
